Dr Floyd E Jernigan, MD | |
109 Bee St, Charleston, SC 29401-5703 | |
(843) 577-5011 | |
Not Available |
Full Name | Dr Floyd E Jernigan |
---|---|
Gender | Male |
Speciality | Internal Medicine - Pulmonary Disease |
Location | 109 Bee St, Charleston, South Carolina |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1376636258 | NPI | - | NPPES |
NCG490B | Other | NC | MEDICARE PTAN |
Entity Name | The Mcdowell Hospital Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1699772657 PECOS PAC ID: 2264343979 Enrollment ID: O20031107000487 |
News Archive
Baxa Corporation announces the launch of a new program for sourcing its IntelliFill i.v. Automation and IntelliFlowRx Pharmacy Workflow Manager products. The Baxa IntelliSource(TM) program offers health-system pharmacies access to the automation and software they need to ensure that each dose dispensed is safe and accurate - without making capital investments, paying one-time setup fees or signing capital leases.
Researchers have discovered a way to better predict progression of Alzheimer's disease. By imaging microglial activation levels with positron emission tomography, researchers were able to better predict progression of the disease than with beta-amyloid PET imaging, according to a study published in the April issue of the Journal of Nuclear Medicine.
Imagine needing a critical test at your local hospital, but having to wait days to be tested because there was no laboratory professional available to run the tests. This scene seems unimaginable, but with the federal government estimating that nearly 140,000 new medical lab professionals are needed by 2012 and only 50,000 are expected to be trained on time, this scenario is a reality in some parts of the country. Some states, like California, are taking aggressive action to reverse this trend.
Home Diagnostics, Inc., a leading manufacturer and marketer of diabetes testing supplies, announced today that it signed a definitive merger agreement with Nipro Corporation (Tokyo Stock Exchange and Osaka Stock Exchange Ticker Code 8086), a global manufacturer and distributor of medical devices, pharmaceutical products and medical and glass products headquartered in Osaka, Japan, under which Nipro will acquire all outstanding shares of Home Diagnostics' common stock, $.01 par value, for a cash purchase price of $11.50 per share (or aggregate consideration of approximately $215 million).
› Verified 6 days ago
Entity Name | Transylvania Community Hospital Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1174549208 PECOS PAC ID: 4880592427 Enrollment ID: O20031222000135 |
News Archive
Baxa Corporation announces the launch of a new program for sourcing its IntelliFill i.v. Automation and IntelliFlowRx Pharmacy Workflow Manager products. The Baxa IntelliSource(TM) program offers health-system pharmacies access to the automation and software they need to ensure that each dose dispensed is safe and accurate - without making capital investments, paying one-time setup fees or signing capital leases.
Researchers have discovered a way to better predict progression of Alzheimer's disease. By imaging microglial activation levels with positron emission tomography, researchers were able to better predict progression of the disease than with beta-amyloid PET imaging, according to a study published in the April issue of the Journal of Nuclear Medicine.
Imagine needing a critical test at your local hospital, but having to wait days to be tested because there was no laboratory professional available to run the tests. This scene seems unimaginable, but with the federal government estimating that nearly 140,000 new medical lab professionals are needed by 2012 and only 50,000 are expected to be trained on time, this scenario is a reality in some parts of the country. Some states, like California, are taking aggressive action to reverse this trend.
Home Diagnostics, Inc., a leading manufacturer and marketer of diabetes testing supplies, announced today that it signed a definitive merger agreement with Nipro Corporation (Tokyo Stock Exchange and Osaka Stock Exchange Ticker Code 8086), a global manufacturer and distributor of medical devices, pharmaceutical products and medical and glass products headquartered in Osaka, Japan, under which Nipro will acquire all outstanding shares of Home Diagnostics' common stock, $.01 par value, for a cash purchase price of $11.50 per share (or aggregate consideration of approximately $215 million).
› Verified 6 days ago
Entity Name | Blue Ridge Regional Hospital, Inc. |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1679570840 PECOS PAC ID: 0648181966 Enrollment ID: O20060410000335 |
News Archive
Baxa Corporation announces the launch of a new program for sourcing its IntelliFill i.v. Automation and IntelliFlowRx Pharmacy Workflow Manager products. The Baxa IntelliSource(TM) program offers health-system pharmacies access to the automation and software they need to ensure that each dose dispensed is safe and accurate - without making capital investments, paying one-time setup fees or signing capital leases.
Researchers have discovered a way to better predict progression of Alzheimer's disease. By imaging microglial activation levels with positron emission tomography, researchers were able to better predict progression of the disease than with beta-amyloid PET imaging, according to a study published in the April issue of the Journal of Nuclear Medicine.
Imagine needing a critical test at your local hospital, but having to wait days to be tested because there was no laboratory professional available to run the tests. This scene seems unimaginable, but with the federal government estimating that nearly 140,000 new medical lab professionals are needed by 2012 and only 50,000 are expected to be trained on time, this scenario is a reality in some parts of the country. Some states, like California, are taking aggressive action to reverse this trend.
Home Diagnostics, Inc., a leading manufacturer and marketer of diabetes testing supplies, announced today that it signed a definitive merger agreement with Nipro Corporation (Tokyo Stock Exchange and Osaka Stock Exchange Ticker Code 8086), a global manufacturer and distributor of medical devices, pharmaceutical products and medical and glass products headquartered in Osaka, Japan, under which Nipro will acquire all outstanding shares of Home Diagnostics' common stock, $.01 par value, for a cash purchase price of $11.50 per share (or aggregate consideration of approximately $215 million).
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Floyd E Jernigan, MD 1902 Houghton Dr, Charleston, SC 29412-2906 Ph: (843) 577-5011 | Dr Floyd E Jernigan, MD 109 Bee St, Charleston, SC 29401-5703 Ph: (843) 577-5011 |
News Archive
Baxa Corporation announces the launch of a new program for sourcing its IntelliFill i.v. Automation and IntelliFlowRx Pharmacy Workflow Manager products. The Baxa IntelliSource(TM) program offers health-system pharmacies access to the automation and software they need to ensure that each dose dispensed is safe and accurate - without making capital investments, paying one-time setup fees or signing capital leases.
Researchers have discovered a way to better predict progression of Alzheimer's disease. By imaging microglial activation levels with positron emission tomography, researchers were able to better predict progression of the disease than with beta-amyloid PET imaging, according to a study published in the April issue of the Journal of Nuclear Medicine.
Imagine needing a critical test at your local hospital, but having to wait days to be tested because there was no laboratory professional available to run the tests. This scene seems unimaginable, but with the federal government estimating that nearly 140,000 new medical lab professionals are needed by 2012 and only 50,000 are expected to be trained on time, this scenario is a reality in some parts of the country. Some states, like California, are taking aggressive action to reverse this trend.
Home Diagnostics, Inc., a leading manufacturer and marketer of diabetes testing supplies, announced today that it signed a definitive merger agreement with Nipro Corporation (Tokyo Stock Exchange and Osaka Stock Exchange Ticker Code 8086), a global manufacturer and distributor of medical devices, pharmaceutical products and medical and glass products headquartered in Osaka, Japan, under which Nipro will acquire all outstanding shares of Home Diagnostics' common stock, $.01 par value, for a cash purchase price of $11.50 per share (or aggregate consideration of approximately $215 million).
› Verified 6 days ago
Dr. Jeffrey Peter Yourshaw, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 169 Ashley Ave, Room 202 Main Hospital Msc 333, Charleston, SC 29425 Phone: 843-876-4807 Fax: 843-876-4809 | |
Jennifer Lee Martin, D.O. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 171 Ashley Ave, Charleston, SC 29425 Phone: 843-792-1414 | |
Nikko Rowe Asuncion Tabliago, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 169 Ashley Ave Rm 202, Charleston, SC 29425 Phone: 843-792-2575 | |
Moses K Asempah, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 169 Ashley Avenue, Room 202 Main Hospital Msc333, Charleston, SC 29425 Phone: 717-491-3745 | |
Paige Nicole Laverick, PA-C Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 171 Ashley Ave, Charleston, SC 29425 Phone: 843-792-1414 | |
Amit Agrawal, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 171 Ashley Ave, Charleston, SC 29425 Phone: 843-792-1414 | |
Yevgeniy Gelfand, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 67 President St, Charleston, SC 29425 Phone: 843-792-0111 |